This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!
Menu
BOOK NOW
Key Sessions
Antonio Lanzavecchia, M.D
Mechanisms of Antibody-mediated Resistance to Infectious Diseases
National Institute of Molecular Genetics, INGM; Humabs BioMed, a subsidiary of Vir Biotechnology
June 9 - Live Sessionskeyboard_arrow_right

June 9 - Live Sessions

keyboard_arrow_leftSearch & Filter
search

June 9 - Live Sessions

search
June 9 - Live Sessions 09:45 - 10:1530 mins
SCIENTIFIC BRIEFING: Improved Lab Productivity for Full Characterisation of Biologics Getting Accurate and Reliable Results: From Early Selection to Validation to Bio-therapeutics Manufacturing
  • Lisette Bronswijk - Manager FAS BioAnalytics South Europe, Sartorius
June 9 - Live Sessions 10:30 - 11:0030 mins
Scientific Briefing
Are Unvalidated Antibodies Undermining Your Research?
  • Monique Seymour - Scientific Sales Executive, Rapid Novor
June 9 - Live Sessions 11:15 - 12:1560 mins
Keynote Presentation with Introduction by Session Chair
Mechanisms of Antibody-mediated Resistance to Infectious Diseases
  • Antonio Lanzavecchia, M.D - Group Leader; SVP and Senior Research Fellow, National Institute of Molecular Genetics, INGM; Humabs BioMed, a subsidiary of Vir Biotechnology
  • Paul Parren, PhD - EVP, Head of R&D and Professor, Lava Therapeutics and Leiden University
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
June 9 - Live Sessions 12:30 - 13:1545 mins
Live Panel Discussion & Speaker Q&A
Advances in T-Cell Engaging Therapies
  • Kerry Chester, PhD - Professor of Molecular Medicine, UCL Cancer Institute
  • Christian Klein, PhD - Head Oncology Programs, Roche Innovation Center Zurich
  • Roeland Lameris, M.D. - Resident Internal Medicine and PhD Student, Amsterdam UMC
  • Paul Hughes, Ph.D. - Scientific Director, Amgen
  • Nadine van Montfoort , Ph.D. - Assistant Professor and Group Leader, Leiden University Medical Centre
  • Stephen Russell, M.D., Ph.D. - Professor of Molecular Medicine, Mayo Clinic
  • Gernot Stuhler, MD - Immunotherapy Lab, University Hospital Würzburg
June 9 - Live Sessions 13:30 - 14:0030 mins
Scientific Briefing
Antibody Production - Fast and Furious at a COVID-19 Pandemic Response Pace
  • Oren Beske, Ph.D. - Amalgamator of Business and Biology, ATUM
June 9 - Live Sessions 14:15 - 14:4530 mins
Scientific Briefing
Uncovering Critical Receptors and Assessing Target Specificity of Biotherapeutics
  • Diogo Rodrigues Ferreirinha - European Business Development Manager, Retrogenix Limited
June 9 - Live Sessions 15:00 - 15:3030 mins
Scientific Briefing
Amplifying Antibody Diversity with Single-cell Screening and Immune Repertoire Sequencing
  • Kevin Heyries, Ph.D. - Co-founder & Head of Business Development, AbCellera
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
June 9 - Live Sessions 15:45 - 16:3045 mins
Live Panel Discussion & Speaker Q&A
Payloaded Antibodies and Immune-oncology – Crossroads
  • Esther Breij, PhD - Senior Director, Translational Research, Genmab BV
  • Francesca Zammarchi, PhD - Head of Pharmacology, ADC Therapeutics
  • Sara Mangsbo, PhD - Senior Associate Lecturer, Uppsala University
  • Betsy Gray, Ph.D. - Senior Scientist, Immunology, Seagen
  • Myriam Fabre, Ph.D. - R&D Director, Oncomatryx Biopharma S.L.
  • Michael Alonso, Ph.D. - Vice President, Immunology and Pharmacology, Bolt Biotherapeutics
June 8 - Live Sessions
NextJune 10 - Live Sessions
Filter
Streams
Formats
Choose Day